Hematolymphoid Pathology Flashcards

1
Q

What are red blood cells (RBCs)?

A

Main function is to carry oxygen around in the blood from the lungs to other organs/ tissues and to carry CO2 in the reverse direction. This is accomplished by binding ox oxygen/ CO2 to hemoglobin, which is by far the most common protein found in RBCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Anemia?

A

A reduction in the oxygen-transporting capacity of blood, resulting from a decrease in circulating red cell mass, below normal limits. Too few RBCs. *most common.
-Measure by looking at the hemoglobin concentration in the blood (reflects oxygen-transporting capacity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How can anemia be classified?

A

Based on the underlying mechanism or based on the morphological appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the classifications of anemia, based on underlying mechanisms (pathophysiological classification)

A
  1. Anemia can stem from decreased red blood cell (RBC) production (bone marrow is at fault)
  2. Blood loss (problem lies outside the bone marrow, in the circulation - peripheral problem)
  3. Increased destruction (hemolytic anemias - peripheral problem)
  4. Disturbed erythroid proliferation (diminished erythropoiesis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe anemia resulting from decreased red blood cell (RBC) production

A

-Defect in early stem cells (e.g. aplastic anemia, pure red cell aplasia)
-Defective cell division in maturing precursors (e.g. vitamins B12/folate deficiency; myelodysplasia)
-Defective hemoglobin synthesis in maturing precursors (e.g. iron deficiency; hereditary thalassemias)
-Bone marrow replacement (by tumour, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe anemia resulting from blood loss

A

-Acute (e.g. trauma or hemorrhage)
-Chronic (e.g. gastrointestinal tract lesions, gynecologic disturbances, reproductive female, slow-bleeding mucosal tumours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe anemia resulting from increased destruction (hemolytic anemias)

A
  1. Intrinsic (intracorpuscular) abnormalities (RBCs are abnormal):
    -hereditary (usually): 1. membrane abnormalities/defects (e.g. hereditary spherocytosis), 2. enzyme deficiencies/defect (e.g. glucose-6-phosphate dehydrogenase deficiency), 3. disorders of hemoglobin synthesis - structurally abnormal globin synthesis (hemoglobinopathies, e.g. sickle cell anemia, thalassemia syndromes)
    -acquired: membrane defect: paroxysmal nocturnal hemoglobinuria (hereditary but develops later in life due to stimulus)
  2. Extrinsic (extracorpuscular) abnormalities (extracellular defect affecting normal RBCs):
    -antibody-mediated (immune mediated damage): 1.alloantibodies (e.g. transfusion reactions), 2.autoantibodies (e.g. idiopathic autoimmune diseases)
    -mechanical trauma to red cells (nonimmune damage): 1. microangiopathic hemolytic anemias (e.g. disseminated intravascular coagulation (DIC), 2. defective cardiac valves, 3. infections (e.g. malaria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe anemia resulting from disturbed erythroid proliferation (diminished erythropoiesis)

A
  • Disturbed proliferation and differentiation of stem cells (aplastic anemia, pure red cell aplasia)
  • Disturbed proliferation and maturation of erythroblasts: 1.defective DNA synthesis (deficiency or impaired use of B12 and folic acid, megaloblastic anemias), 2. anemia of renal failure (erythropoietin deficiency), 3. anemia of chronic, 4. anemia of endocrine disorders, 5. defective hemoglobin synthesis (deficient heme syntheis - iron deficiency, deficient globin synthesis (thalassemias)
  • Marrow replacement (e.g. by primary hematopoietic neoplasms such as acute leukemia)
  • Marrow infiltration (myophthisis anemia - e.g. metastatic neoplasms, granulomatous disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is anemia classified based on morphology

A

Using peripheral blood counts and smears (stained), the morphological classification of anemia is based on:
- size RBC is either normocytic, microcytic or macrocytic, measured by MCV (mean cell volume)
-degree of hemoglobinization - colour “redness”: RBC is either normochromic or hypochromic, measured on the hemogram by the MCHC (mean corpuscular/cell hemoglobin concentration)
-shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the classifications of anemia based on morphology

A
  1. Normochromic, normocytic = normal, pink colour, normal size e.g. acute blood loss, many chronic diseases and malignancies
  2. Hypochromic, microcytic = too pale (low MCH), too small (low MCV) e.g. iron deficiency anemia, thalassemias (hereditary disorders with decreased production of Hb due to Hb gene deletions)
  3. Macrocytic = too big (high MCV), always normochromic, e.g. vitamin B12/folate deficiency, liver disease, myelodysplasia
  4. Abnormally shaped e.g. sickle cell anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the clinical presentation of anemia?

A

-decreased oxygen delivery to organs/tissues
-symptoms: generalized weakness, malaise (unwell feeling), headaches, easily tired, fainting spells, shiny tongue, fragile and concave fingernails
-signs: compensatory physiological cardiovascular and respiratory changes, trying to increase oxygen delivery to tissues (increased heart rate, increased cardiac stroke volume, decreased peripheral vascular resistance, increased respiratory rate, shortness of breath (SOB) on exertion)
-late signs of anemia: pale mucous membranes, heart murmur, heart failure (peripheral edema, worsening shortness of breath)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe further the anemia of blood loss (hemorrhage)

A

Can be due to:
1. Acute bleeding (hemorrhage):
-effects are mainly due to loss of intravascular volume, which if massive can lead to cardiovascular collapse, shock and death
-if blood loss is >20% of blood volume, immediate threat is hypovolemic shock rather than anemia
-if patients survives, hemodilution begins and maximizes in 2 to 3 days, when the full extend of RBC loss is seen
-normocytic and normochromic. recovery occurs via a compensatory rise in erythropoietin levels, stimulating increased bone marrow RBC production and reticulocytosis
2. Slow chronic blood loss:
-iron stores are gradually depleted when blood loss is occurring to outside the body e.g. mucosal bleeding. iron is essential for hemoglobin synthesis and erythropoiesis, and its deficiency leads to chronic anemia of underproduction i.e. iron deficiency anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are hemolytic anemias?

A

All causes have in common accelerated red cell destruction (hemolysis). Red cell life span is shortened to less than the normal 120 days. Regardless of cause, low tissue O2 levels trigger increased erythropoietin from the kidney, which in turn stimulates erythroid hyperplasia in the bone marrow and increased release of reticulocytes into the blood - hallmarks of all hemolytic anemias. In severe hemolytic anemias, the erythropoietic drive may be so pronounced that extra-medullary hematopoiesis appears in the liver, spleen and lymph nodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are hemolytic anemias organized?

A
  1. One approach groups them according to pathogenesis - whether the RBC defect is intrinsic to the RBCs (intracorpuscular) or extrinsic to them (extracorpuscular)
  2. A second more clinical approach classifies hemolytic anemias according to whether the hemolysis is primarily occurring extravascular (most) or intravascular.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe extravascular hemolysis

A

Caused by defects that increase the destruction of either partly damaged or antibody-coated RBCs by phagocytosis in the spleen. Extreme alterations of shape are necessary for red cells to navigate the sluggish blood flow through splenic sinusoids and any reduction in red cell deformability makes this passage difficult; abnormal RBCs become recognized and phagocytosed by resident splenic macrophages. Findings that are relatively specific for extravascular hemolysis (compared to intravascular):
1. Hyperbilirubinemia and jaundice, from degradation of hemoglobin in macrophages
2. Enlarged spleen (spenomegaly) due to “work hyperplasia” of phagocytes in the spleen
3. Formation of bilirubin-rich gallstones (pigment stones) and increased risk of choleithiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe intravascular hemolysis

A

Characterized by such severe injuries that RBCs literally burst within the circulation. May be due to mechanical forces (e.g. turbulence over a defective heart valve), biochemical or physical agents that severely damage the red cell membrane (e.g. complement fixation, bacterial toxins, intracellular parasites like malaria, or heat). Findings that distinguish intravascular hemolysis from extravascular hemolysis include:
1. Hemoglobinemia, hemoglobinuria, and hemosiderinuria (hemoglbin released into the circulation is small enough to filter into the urinary space, is partly processed into hemosiderin, then lost in the urine)
2. Loss of iron may lead to iron deficiency if hemolysis is persisten
3. Decreased serum levels of haptoglobin, a plasma protein that binds free hemoglobin before it is removed from the circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List causes of anemia

A
  • Hereditary spherocytosis
  • Sickle cell anemia
  • Thalassemia
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Immune hemolytic anemias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe hereditary spherocytosis

A

Autosomal dominant, caused by mutations affecting RBC membrane skeleton, leading to loss of membrane and eventual conversion of red cells to spherocytes, which are phagocytosed and removed in the spleen. Clinically present as anemia with spenomegaly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe sickle cell anemia

A

Autosomal recessive, abnormal hemoglobin resulting from a B-globin mutation that causes deoxygenated hemoglobin to self-associate into long polymers that distort the red cell, producing a sickle shape. Blockage of vessels by sickled cells causes pain crises and tissue infarction, particularly of the marrow and spleen. RBC damage caused by repeated bouts of sickling results in moderate to severe hemolytic anemia. Patients are at a high risk for bacterial infections and strokes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe Thalassemia

A

Autosomal codominant disorders caused by mutations/deletions in a- or B-globin that reduce hemoglobin synthesis, resulting in microcytic, hypochromic anemia. A relative excess of the unpaired globin chains results in formation of aggregates that damage red cell precursors to further impair erythropoiesis, and also result in some degree of extravascular hemolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe Glucose-6-phosphate dehydrogenase (G6PD) deficiency

A

X-linked disorder caused by mutations that destabilize G6PD, affecting the hexose monophosphate shunt (glutathione) metabolic pathway. G6PD deficiency makes red cells susceptible to oxidant damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are anemias of diminished erythropoiesis?

A

-include anemia caused by inadequate dietary supply of nutrients, especially iron (needed for hemoglobin), folic acid, and vitamin B12 (needed for DNA synthesis in nucleated erythroid precursors)
-other anemias of this type are associated with bone marrow failure (aplastic anemia), systemic inflammation/tumor (anemia of chronic disease), or direct bone marrow infiltration by tumour or inflammatory cells (myelophthisic anemia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List the common and important causes of anemias of diminished erythropoiesis

A
  1. Iron deficiency anemia
  2. Anemia of chronic inflammation (anemia of chronic disease)
  3. Megaloblastic anemia
  4. Aplastic anemia
  5. Myelophthisic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe iron deficiency anemia

A

Caused by chronic bleeding or inadequate iron intake; reduced iron results in insufficient hemoglobin synthesis which results in hypochromic, microcytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe anemia of chronic inflammation (anemia of chronic disease)

A

Caused by inflammatory cytokines, which increase hepcidin levels (secreted from liver) and thereby sequester iron in macrophages; cytokines also suppress erythropoietin production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe megaloblastic anemia

A

Caused by deficiencies of folate or vitamin B12 that leads to inadequate synthesis of thymidine, thus defective DNA replication. Results in enlarged abnormal hematopoeitic precursors (megaloblasts) with large immature nuclei, ineffective hematopoiesis, macrocytic anemia, and (in most cases) pancytopenia (as it affects all the marrow lineages)

27
Q

Describe aplastic anemia

A

Caused by bone marrow failure (hypocellularity) resulting from diverse causes, including exposures to toxins and radiation, idiosyncratic reactions to drugs and viruses, and inherited defects in telomerase and DNA repair.

28
Q

Describe myelophthisic anemia

A

Caused by replacement of bone marrow by infiltrative processes such as metastatic carcinoma and granulomatous disease, leading to marrow fibrosis. Results in the appearance of early erythroid and granulocytic precursors (leukoerythroblastosis) and teardrop-shaped red cells in the peripheral blood.

29
Q

What are white blood cell (WBC) disorders?

A

Include deficiencies (leukopenia) and increased proliferations which may be reactive or neoplastic. Reactive proliferation in response to a primary, often infectious disease is common. Neoplastic disorders are less common, but more ominous: they cause approximately 9% of all cancer deaths in adults and 40% in children under the age of 15.

30
Q

What is it called when there are too many red blood cells?

A

Polycythemia, also referred to as erythrocytosis

31
Q

What are non-neoplastic disorders of WBCs?

A

Quatitative abnormalities - increased WBC count (leukocytosis), decreased WBC count (leukopenia).

32
Q

What is leukopenia?

A

Results most commonly from a decrease in granulocytes (most numerous circulating white cells). Too few WBCs.

33
Q

What is neutropenia/ agranulocytosis?

A

A reduction in the number of granulocytes (most problematic) in blood is called neutropenia. Neutropenic persons are susceptible to severe, potentially fatal bacterial and fungal infections. The risk of infection rises sharply as the neutrophil count falls below 500 cells/µL, this is agranulocytosis - risk of overwhelming sepsis.

34
Q

What are the pathogenic mechanisms underlying neutropenia?

A
  1. Decreased of ineffective production of granulocytes - most often caused by general marrow hypoplasia (e.g. cancer chemotherapy, aplastic anemia) or marrow replacement (e.g. leukemia). Usually there is accompanying anemia and reduced platelets. Usually there is accompanying anemia and reduced platelets (only neutrophil production suppressed - other blood lineages unaffected - most common cause is drug.
  2. Increased granulocyte destruction/ loss - immune mediated injury (triggered in some cases by drugs, or autoimmune diseases) or overwhelming bacterial, fungal or rickettsial infections can result in increased peripheral use and depletion of neutrophils (idopathic - unknown).
35
Q

What is reactive leukocytosis?

A

Increased number of white cells in the blood is common in many inflammatory states, caused by microbial and non microbial stimuli. Leukocytosis are relatively nonspecific and are classified according to the particular white cell type affected (WBC involved)

36
Q

List the types of reactive leukocytosis

A
  1. Neutrophilic leukocytosis (neutrophils)
  2. Eosinophilic leukocytosis (eosinophilia - eosinophils)
  3. Basophilic leukocytosis (basophilia)
  4. Monocytosis (monocytes)
  5. Lymphocytosis (lymphocytes)
37
Q

Describe neutrophilic leukocytosis (neutrophils)

A
  • Acute bacterial (especially pyogenic) infections;
  • Sterile inflammation/ severe tissue damage caused e.g. by tissue necrosis (myocardial infarction, burns)
38
Q

Describe eosinophilic leukocytosis (eosinophilia - eosinophils)

A
  • Allergic disorders/ infections e.g. athsma, hay fever, allergic skin diseases
  • Parasitic infestations
  • Drug reactions
  • Certain malignancies e.g. hodgkin lymphoma and some non-hodgkin lymphomas
  • Collagen vascular disorders/ some vasculitis`
39
Q

Describe basophilic leukocytosis (basophilia)

A

Rarely benign, often indicative of myeloproliferative neoplasm e.g. chronic myeloid leukemia. Tumours - can induce high WBC count.

40
Q

Describe monocytosis (monocytes)

A

Leukocytosis.
- Chronic infections e.g. tuberculosis, bacterial endocarditis, rickettsiosis, malaria
- Collagen vascular diseases e.g. systemic lupus erythematosus
- Inflammatory bowel diseases e.g. ulcerative colitis

41
Q

Describe lymphocytosis (lymphocytes)

A

Leukocytosis.
- Accompanies monocytosis in many disorders associated with chronic immunologic stimulation e.g. tuberculosis, brucellosis
- Viral infections e.g. hepatitis A, cytomegalovirus, Epstein-Barr virus (EBV)
- Bordetella pertussis infection (whooping cough) - bacteria

42
Q

What is reactive lymphadenitis (reactive lymph nodes)?

A

Infections and nonmicrobial inflammatory stimuli often activate defensive immune cells in lymph nodes. Any immune response against foreign antigens can cause lymph node enlargement *lymphadenopathy). Infections causing lymphadenitis are many, and the histologic appearance of the lymph node reaction is often nonspecific.

43
Q

What are neoplastic disorders of WBCs?

A

Myeloid or lymphoid malignancies (all these tumours are malignant). The most important disorders of white blood cells are neoplasms. Range of behaviours from very aggressive tumours to indolent tumours.

44
Q

How are neoplastic disorders of WBCs classified

A

Relies on a mixture of morphologic and molecular criteria, including lineage specific protein markers and genetic findings. There are two main categories based on the origin and differentiation state of the tumour cells: lymphoid (includes plasma cells) and myeloid (includes histiocytic) neoplasms. May present as leukemia (primarily growing in the bone marrow medulla) or as an extramedullary tumour (mass outside of the bone marrow). Both myeloid and lymphoid tumours are further subdivided into acute and chronic neoplasms.

45
Q

Describe lymphoid neoplasms

A

Characteristically manifest as leukemias (primarily involving bone marrow and peripheral blood), and others tend to present as lymphomas (tumour masses in lymph nodes or other tissues).
Plasma cell tumours usually arise within bones and cause systemic symptoms related to the production of a complete or partial monoclonal immunoglobulin.
All lymphoid neoplasms have the potential to spread to lymph nodes and other tissues, especially liver, spleen, bone marrow and peripheral blood.
Because of their clinical behaviour, the diagnosis of lymphoid neoplasms is based on the morphologic and molecular characteristics of the tumour cells, more than their clinical presentation.

46
Q

Describe leukemias

A

Tumours in the bone marrow (bone medulla).
Definition: neoplasms of blood-forming (hematopoietic) cells which multiply in the bone marrow, thus replacing normal bone marrow. In most cases, the abnormal cells also spill over in the blood circulation, and in some cases, they secondarily infiltrate other organs.

47
Q

Describe acute leukemia

A
  • Clinical presentation: accumulation of blast cells (very immature cells) in the bone marrow. Usually rapid onset “acute”, rapid progression and fatal in weeks if not treated.
  • Bone pain (kids)
  • Bone marrow failure (normal marrow is being replaced) - cytopenias. Anemia (pale, weak), neutropenia (prone to infection), thrombocytopenia (bleeding)
  • Circulation of blast cells - increased WBC count - small blood vessel obstruction, DIC
  • Infiltration of organs - organomegaly e.g. liver, spleen, lymph nodes, skin, mucous membranes
48
Q

Describe acute lymphoblastic leukemia (ALL)

A
  • children > adolescents > adults
  • 85% B-cell origin (immature precursor B lymphocytes)
  • 15 % precursor T-cell origin (most precursor T-cell neoplasms present in the mediastinum/ thymus; thus by definition, they are acute lymphoblastic lymphomas rather than leukemias)
  • large immature nuclei
49
Q

Describe acute myeloid leukemia (AML)

A
  • the neoplastic cells are blocked at an early stage of myeloid cell development.
  • typically occurs in middle aged adults (30s). Typically have worse prognosis that acute lymphoblastic leukemia (children are more resilient).
  • diverse acquired mutations lead to expression of abnormal transcription factors, which interfere with myeloid differentiation. Immature cells (blasts) accumulate in the marrow, replacing normal elements, and frequently circulation in the peripheral blood.
  • an aggressive tumour presenting within 1-3 weeks of onset of symptoms.
  • clinical signs and symptoms: related to the replacement of normal marrow by blasts (fatigue, pallor - due to anemia - abnormal bleeding - due to thrombocytopenia/ low platelets - and infections - due to neutropenia).
  • diagnosis: blood and bone marrow examination: routine stains for morphology, ancillary tests are necessary, for subtyping of leukemias, treatment decisions and prognosis
  • treatment and outcome: combination chemotherapy (multiple drugs given together to increase effectiveness and combat resistance), cranial irradiation +/- testicular irradiation, bone marrow transplantation, good> 85% cure rate for childhood ALLs, but cure much rarer, 25 % in AMLs.
50
Q

Describe chronic lymphocytic leukemia (CLL)

A
  • most common adult leukemia, mostly in middle aged to elderly adults
  • > 90% are B lymphocyte origin
  • clinical course: slow growing, but incurable. Asymptomatic till advanced disease (bone marrow replacement - neutropenia, thrombocytopenia, anemia). 10-15% develop an autoimmune blood disorder.
51
Q

Describe myeloid neoplasms

A
  • typically give rise to proliferations that involve the bone marrow and replace normal marrow elements. Three broad categories of myeloid neoplasms: acute myeloid leukemia (AML), chronic myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS). Divisions between myeloid neoplasms sometimes blur e.g. both MDS and myeloproliferative neoplasms often transform to AML, and some neoplasms have features of both MDS and MPN.
52
Q

Describe chronic myeloproliferative neoplasms (MPN)

A

Uncontrolled myeloid proliferation with full differentiation, gradually replacing the bone marrow, spilling into the blood, homing to secondary hematopoietic organs.
- the neoplastic clone continues to undergo terminal differentiation, but exhibits increased dysregulated growth
- typically affects middle aged or older adults
- common pathogenic feature is the presence of mutated, constitutively activated tyrosine kinases, or other acquired aberrations in signalling pathways that lead to growth factor independent proliferation. This is important therapeutically because of the availability of tyrosine kinase inhibitors (TKIs)
- commonly are associated with an increase in one or more of the formed elements (red cells, platelets, and/ or granulocytes) in the peripheral blood, often with enlargement of secondary hematopoietic organs (spleen, liver and lymph nodes).
- there are 4 major diagnostic entities: chronic myeloid leukemia (CML), Polycythemia Vera (increased RBCs), essential thrombocytosis (increased platelets), and primary myelofibrosis (progressive marrow fibrosis)

53
Q

Describe chronic myeloid leukemia

A
  • increased granulocytes, high blood WBC
  • most common, typically affecting adults (25-60 years) - 20% of leukemias
  • mainly shows as increased granulocytic lineage, although the defect starts in a pluripotent stem cell (defect is present in myeloid, erythroid, megakaryocytic, lymphoid cells)
  • disease course typically was 3-5 years, now much prolonged due to better treatment modalities, but most often terminates by transformation to acute leukemia (death)
    -has a diagnostic cytogenetic abnormality, the BCR-ABL fusion gene (philadelphia chromosome) that produces a constitutively active BCR0ABL tyrosine kinase - keeps proliferation going
54
Q

Describe mylodysplastic syndromes (MDS)

A

Chronic bone marrow neoplasm showing clonal maturational defects in stem cells. Results in: ineffective hematopoiesis (proliferation, with full but abnormal differentiation) - peripheral blood cytopenias
- outcome: death related to complications of cytopenias. transformations to acute myeloid leukemia, in 10-40% of patients kept alive by transfusions and treatment of infections.
- media survival 2-30 months (depending on type)
-full differentiation occurs but in a disordered and ineffective fashion, leading to the appearance of dysplastic marrow precursors that proliferate and start to replace normal bone marrow elements. the abnormal stem cell clone in the bone marrow is genetically unstable, prone to additional mutations and eventual transformations
-typically seen in older adults

55
Q

Describe lymphomas

A

Mixed group of solid tumours, derived from lymphoid cells. Lymphomas arise from malignant transformations of a single B or T lymphocyte, at a specific stage of development i.e. they are monoclonal. Extramedullary WBC tumours (arising outside of the bone marrow) are most commonly lymphomas.
- there are two groups of lymphomas: Hodgkin lymphomas and non-Hodgkin lymphomas. Both arise most commonly in lymphoid tissues, set apart by morphology, biologic behaviour and clinical treatment.

56
Q

Describe the WHO (world health organization) classification of lymphoid neoplasms

A

Considers the morphology, cell or origin (determined by immunophenotyping), clinical features, and genotype (e.g. karyotype, presence of viral genomes) of each entity. Actual diagnostic entities are numerous, but are broadly grouped under the following categories:
1. Precursor B cell (cell resemble bone marrow precursors of B lymphocytes)
2. Mature B cell (cells resemble different stages of mature peripheral B cells)
3. Precursor T cell (cells resemble bone marrow or thymic precursors of T lymphocytes)
4. Mature T cell (cells resemble different stages of mature peripheral T cells).

57
Q

Describe Hodgkin Lymphoma

A

Orderly spread from LN (lymph node) group to LN group. More often central or axial nodes. Extranodal presentations are very rare. Few tumour cells, in the background of many inflammatory cells.
- unusual B cell lymphoma, consisiting mostly of reactive inflammatory cells, while the large malignant cells, called Reed-Sternberg or RS cells, form very minor part of the mass. The inflammatory cell infiltrate is induced by cytokines, some secreted by RS cells
- HL is most common in teens and young adults, presenting with painless large lymph nodes, with or without symptoms (fever, weight loss, night sweats).
- diagnosis is usually made on a lymph node/ tissue biopsy, based on presence of two features: neoplastic reed-sternberg cells and variants (minority), and benign inflammatory cells in the background (majority) - lymphocytes, histiocytes, eosinophils, plasma cells, neutrophils
- treatment is radiotherapy and/ or chemotherapy, with an overall 5-year survival rate of up to 90%. However, treated long-term survivors have a high risk of second malignancies e.g. lung or breast cancer.

58
Q

Describe Non-Hodgkin lymphoma

A

Noncontinuous spread in the body. More often peripheral nodes. Extranodal in 30-40% of cases. Tumour cells comprise most cells in the mass.
- two broad categories: B and T/NK cell types
- each category further subdivided into: precursory (lymphoblastic) lymphomas, mature cell lymphomas, or cell proliferations of uncertain malignant potential
- 90% NHL are B cell lymphomas, 10% T cell (this is north america)
- clinical presentations: enlarged palpable painless lymph nodes, enlarged spleen or liver (abdominal distension), anemia, infection or bleeding disorder (due to bone marrow replacement by lymphoma, or autoimmune disorders related to lymphoma), gastrointestinal obstruction or bleeding, skin rash (especially T-cell lymphomas) and constitutional symptoms - fever, night sweats, weight loss.
- treatment: watch and wait, chemotherapy (single or multi-agent - don’t want to use too early, may not be able to use later), radiotherapy (localized bulky disease), bone marrow transplantation (not often first-line, may be used in relapse)

59
Q

List the B-cell lymphomas (NHL)

A
  1. Diffuse large B-cell lymphomas (DLBL)
  2. Follicular lymphomas (FL)
  3. Small lymphocytic lymphomas (SLL), this is the same disease as chronic lymphocytic leukemia, only presenting in lymph nodes
60
Q

What is multiple myeloma?

A

Malignant tumour of plasma cells, involving multiple bones (bone marrow) and usually secreting monoclonal immunoglobulin, Lymphoma.
- middle aged to older adults (50-60 years)
- male > females
- clinical presentation: bone pain (due to bone destruction or fractures - vertebrae, ribs, skull), cytopenias (due to marrow replacement), bacterial infections (due to neutropenia and hypogammaglobulinemia), and renal (kidney) insufficiency - hypercalcemia (from bones being broken down), bence-jones proteins, amyloid deposits.

61
Q

What are bleeding disorders?

A

Abnormal bleeding, occurring spontaneously or following an inciting event (e.g. trauma or surgery).
- exists when there is a tendency to spontaneous bleeding or there is excessive bleeding following trauma or surgical procedures
- bleeding disorders may stem from (can occur alone or in combination): abnormalities of blood vessels (increased blood vessel fragility), deficient or dysfunctional platelets, and deranged coagulation mechanism, due to deficient or dysfunction coagulation proteins.

62
Q

Describe bleeding resulting from small vessel fragility

A

Manifested by “spontaneous” appearance of petechia and ecchymoses in the skin and mucous membranes e.g. vitamin C deficiency (scurvy)
- bleeding can also be triggered by systemic conditions that inflame or damage endothelial cells. If severe enough, the vascular lining becomes a prothrombotic surface that activates coagulation producing small clots throughout the circulatory system, a condition known as disseminated intravascular coagulation (*DIC)
- Paradoxically, in DIC platelets and coagulation factors often are used up faster than they can be replaced, resulting in deficiencies that may lead to severe bleeding (referred to as consumptive coagulopathy). Common triggers of DIC are sepsis (generalized infection), major trauma, some cancer, and obstetric complications.

63
Q

Describe thrombocytopenia (decreased number of platelets)

A

Decreased number of platelets, or decreased function of platelets (dysfunction). An important cause of bleeding. However, qualitative defects in platelet function can also result in bleeding (even if the platelet count is normal) e.g. aspirin ingestion.
- clinical signs: manifest superficially, as skin and mucous membrane bleeds e.g. gingiva, gastrointestinal and genitourinary tracts + easy bruising, petechiae, ecchymoses, nosebleeds and menorrhagia (heavy periods), usually milder
- defined as a platelet count less than 150,000 platelets/µL, but only when platelet counts fall to 20,000-50,000 platelets/µL is there an increased risk of post traumatic bleeding and spontaneous bleeding is unlikely until count falls below 5000 platelets/µL.
- although most bleeding due to thrombocytopenia occurs from small, superficial blood vessels in the skin and mucous membranes, larger devastating hemorrhages in the brain can occur.
- when cause is accelerated destruction of platelets, the bone marrow usually shows a compensatory increase in the number of megakaryocytes.
- most common cause of isolated thrombocytopenia is immune thrombocytopenic purpura (ITP)

64
Q

What are the two clinical subtypes of immune thrombocytopenic purpura (ITP)?

A
  1. Acute ITP: uncommon, mostly in children after viral infections (post-viral) and resolves spontaneously in months.
  2. Chronic ITP: relatively common, usually affecting women of child-bearing age (20-40). Gradual onset of skin +/- mucosal bleeding, rarely resolves spontaneously. Is an autoimmune disease where antibodies formed against platelet membrane glycoproteins attach to platelets resulting in premature platelet destruction in the spleen. That the spleen is the major site of destruction of the IgG-coated platelets is proved by the benefits of splenectomy, which normalizes the platelet count in more than two-thirds of patients.
    - treated by immunosuppression (steroids) or splenectomy.